Skip to main content
. 2017 Mar 8;6(4):603–605. doi: 10.3892/mco.2017.1184

Table I.

Characteristics of 14 patients treated with afatinib.

Characteristics n (%)
Age (years)
  Median 71
  Range 55 84
Gender
  Male 7 (50.0)
  Female 7 (50.0)
Performance status
  0–1 10 (71.4)
  2–4 4 (28.6)
Histology
  Adenocarcinoma 14 (100.0)
EGFR mutations
  Ex21 L858R 4 (28.6)
  Ex19 del 9 (63.3)
  Ex18 G719X 1 (7.1)

EGFR, epidermal growth factor receptor.